SciGenom

Founded in 2009, SciGenom Labs has established itself as a key player in the genomics services sector, bridging advanced genomic research between India, Asia, and the USA. Its business model is centered on providing contract research and sequencing services utilizing a robust technology platform that includes Illumina sequencers (HiSeq, MiSeq), Roche 454-FLX, and ABI Sanger systems. The company caters to academic, pharmaceutical, and diagnostic partners, with a noted focus on building genomic resources for South Asian populations. As a private entity, it operates in a high-growth market but faces significant competition and technological obsolescence risks.

Integrated end-to-end genomics platform featuring Illumina NGS sequencers (HiSeq, MiSeq), Roche 454-FLX, ABI Sanger sequencing, and a comprehensive bioinformatics IT infrastructure with LIMS, operating under ISO/NABL/GLP standards.

SciGenom competes in a crowded global genomics services market against large players like BGI, Novogene, and Macrogen, as well as numerous regional labs. Its differentiation is based on its certified Indian laboratory network, focus on South Asian population genomics, and integrated 'Start to Finish' service model.